<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04143568</url>
  </required_header>
  <id_info>
    <org_study_id>106-12</org_study_id>
    <nct_id>NCT04143568</nct_id>
  </id_info>
  <brief_title>Circulating Progenitor Cells Levels in Periodontal Disease Patients</brief_title>
  <official_title>Analysis of Circulating Progenitor Cells Levels in Periodontal Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Messina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, a key role played in the ethiology of periodontitis has been highlighted by a
      subtype of stem cells derived from bone marrow, the circulating endothelial progenitor cells
      (EPCs). EPCs possess the ability to express surface antigens of endothelial and hematopoietic
      stem cells and to assist in maintaining vascular integrity and the repair mechanism of the
      endothelium. Among the main markers for the analysis of EPCs levels are CD34+, CD133+ and the
      kinase insert domain-containing receptor (KDR). CD34+ and CD133+ originate from hematopoietic
      stem cell antigens whereas KDR is a specific marker of endothelial cells. More specifically,
      CD34+ and CD133+/ KDR+ allows less mature and mature EPCs to be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the present study was to investigate the association between endothelial
      progenitor cells (EPCs) levels subtype (CD133+/KDR+), in patients with periodontitis.

      Furthermore, the objective was to determine if the periodontal status influenced CD133+/KDR+
      levels.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2016</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">October 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of endothelial progenitor cells level</measure>
    <time_frame>1 year</time_frame>
    <description>Changes of endothelial progenitor cells level</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">167</enrollment>
  <condition>Metabolic Disease</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Evaluation of endothelial progenitor cells level and correlation of endothelial progenitor cells level with periodontal and cardiovascular disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontitis</arm_group_label>
    <description>Evaluation of endothelial progenitor cells level and correlation of endothelial progenitor cells level with periodontal and cardiovascular disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Evaluation of endothelial progenitor cells level and correlation of endothelial progenitor cells level with periodontal and cardiovascular disease</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Periodontitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        79 healthy subjects, 88 patients with CP. Lipid profile and levels of CD133 and C-reactive
        protein (CRP) were evaluated.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of at least 16 teeth

          -  CP with a minimum of 40% of sites with a clinical attachment level (CAL)

             ≥2mm and probing depth (PD) ≥4mm;

          -  Presence of at least ≥2 mm of crestal alveolar bone loss verified on digital
             periapical radiographs

          -  Presence of ≥40% sites with bleeding on probing (BOP)

        Exclusion Criteria:

          -  Intake of contraceptives

               -  Intake of immunosuppressive or anti-inflammatory drugs throughout the last three
                  months prior to the study

               -  Status of pregnancy or lactation

               -  Previous history of excessive drinking

               -  Allergy to local anaesthetic

               -  Intake of drugs that may potentially determine gingival hyperplasia such as
                  Hydantoin, Nifedipine, Cyclosporin A or similar drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Messina</name>
      <address>
        <city>Messina</city>
        <zip>98125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 26, 2019</study_first_submitted>
  <study_first_submitted_qc>October 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>October 26, 2019</last_update_submitted>
  <last_update_submitted_qc>October 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Messina</investigator_affiliation>
    <investigator_full_name>Gaetano Isola, DDS, PhD</investigator_full_name>
    <investigator_title>Junior Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all collected IPD, all IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>5 years</ipd_time_frame>
    <ipd_access_criteria>IRB university of messina</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

